Neurology

Long-term follow-up for multiple sclerosis patients initially treated with interferon-beta and glatiramer acetate

Our goal was to compare subjects treated with glatiramer acetate (GA) and interferon-beta (IFN-β) in terms of long-term clinical outcomes.

Source link

Related posts

SMA Screening for Newborns Will Soon be Available in Texas

Newsemia

Women more likely to have brain aneurysms than men

Newsemia

Clinical Reasoning: A 47-year-old man with diffuse white matter disease and rapidly progressive dementia

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World